BIO.B News Alert Bio Rad Labs Cl B (BIO.B) 117.35 02/14/2015

New Post Public Reply Private Reply Replies (0) Message Board

Feb 14, 2015 at 12:46 PM

Bio Rad Labs Cl B (BIO. 117.35 $BIO.B

Bio-Rad to Report Fourth-Quarter and Full-Year 2014 Financial Results Thursday, February 26, 2015
Marketwired - Tue Feb 03, 5:57PM CST
Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO. , a global provider of life science research and clinical diagnostic products, will report financial results for the fourth quarter and full year 2014 on Thursday, February 26, 2015, after the close of the market. The company will discuss these results in a conference call scheduled for 2 PM Pacific Standard Time (5 PM Eastern Standard Time) that day.
BIO: 118.36 (+0.79), BIO.B: 117.35 (unch)

Bio-Rad Receives Premarket Application Approval for Its Geenius HIV 1/2 Supplemental Assay
Marketwired - Wed Nov 19, 3:45PM CST
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO. , a global provider of life science research and clinical diagnostic products life science research and clinical diagnostic products, today announced that it has received Premarket Application approval from the U.S. Food and Drug Administration for Bio-Rad's Geenius(TM) HIV 1/2 Supplemental Assay (test).
BIO: 118.36 (+0.79), BIO.B: 117.35 (unch)

Bio-Rad posts 3Q profit
Automated Insights - Tue Nov 04, 5:36PM CST
HERCULES, Calif. (AP) _ Bio-Rad Laboratories Inc. (BIO) on Tuesday reported net income of $11.5 million, or 39 cents per share, in its third quarter.
BIO: 118.36 (+0.79), BIO.B: 117.35 (unch)

Bio-Rad Reports Third-Quarter 2014 Financial Results
Marketwired - Tue Nov 04, 3:28PM CST
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO. , a multinational manufacturer and distributor of life science research and clinical diagnostic products, announced financial results today for the third quarter ended September 30, 2014.
BIO: 118.36 (+0.79), BIO.B: 117.35 (unch)

Bio-Rad paying $55M to resolve US bribery claims
By MARCY GORDON - AP - Mon Nov 03, 4:00PM CST
WASHINGTON (AP) — Bio-Rad Laboratories Inc. has agreed to pay about $55 million to resolve U.S. authorities' allegations that it failed to prevent bribery of officials in Russia, Thailand and Vietnam and falsified records to hide the payments.
BIO: 118.36 (+0.79), BIO.B: 117.35 (unch)

Bio-Rad Laboratories Resolves Foreign Corrupt Practices Act Matters With U.S. Government
Marketwired - Mon Nov 03, 1:16PM CST
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO. , a global provider of life science research and clinical diagnostic products, today announced the full resolution of previously disclosed investigations by the U.S. Department of Justice (DOJ) and Securities and Exchange Commission (SEC) into past violations of the Foreign Corrupt Practices Act (FCPA) that occurred from 2005 to 2010 related to Thailand, Vietnam, and Russia.
BIO: 118.36 (+0.79), BIO.B: 117.35 (unch)

Bio-Rad to Report Third-Quarter 2014 Financial Results Tuesday, November 4, 2014
Marketwired - Wed Oct 08, 5:06PM CDT
Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO. , a global provider of life science research and clinical diagnostic products, will report financial results for the third quarter 2014 on Tuesday, November 4, 2014, after the close of the market. The company will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.
BIO: 118.36 (+0.79), BIO.B: 117.35 (unch)

Bio-Rad Appoints John Goetz as Chief Operating Officer and Announces Other Executive Appointments
Marketwire - Wed Oct 01, 3:15PM CDT
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO. , a global provider of life science research and clinical diagnostics products, today announced the recent appointment of Mr. John Goetz as Chief Operating Officer. In his new role Mr. Goetz is responsible for all operating functions of the company on a global basis, including the Clinical Diagnostics and Life Science segments as well as global sales.
BIO: 118.36 (+0.79), BIO.B: 117.35 (unch)

Bio-Rad Laboratories (BIO. Downgraded From Buy to Hold
at The Street - Tue Sep 30, 8:00AM CDT
Bio-Rad Laboratories (BIO. has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C+.
BIO.B: 117.35 (unch)

Bio-Rad Reports Second-Quarter 2014 Financial Results
Marketwire - Tue Aug 05, 3:15PM CDT
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO. , a global provider of life science research and clinical diagnostic products, today announced financial results for the second quarter ended June 30, 2014.
BIO: 118.36 (+0.79), BIO.B: 117.35 (unch)

Bio-Rad Laboratories appoints Joel McComb to its board
M2 - Mon Jul 28, 6:47AM CDT
Life science company Bio-Rad Laboratories (NYSE:BIO) (NYSE:BIO. disclosed on Friday the election of Joel McComb to its board of directors.
BIO: 118.36 (+0.79), BIO.B: 117.35 (unch)

Bio-Rad Announces the Appointment of New Board Member
Marketwire - Fri Jul 25, 3:15PM CDT
Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO. , a global provider of life science research and clinical diagnostics products, announced today that Joel McComb has been appointed to its Board of Directors.
BIO: 118.36 (+0.79), BIO.B: 117.35 (unch)

Bio-Rad to Report Second-Quarter 2014 Financial Results Tuesday, August 5, 2014
Marketwire - Mon Jul 07, 4:31PM CDT
Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO. , a global manufacturer and distributor of life science research and clinical diagnostic products, will report financial results for the second quarter 2014 on Tuesday, August 5, 2014, following the close of the market. The company will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.
BIO: 118.36 (+0.79), BIO.B: 117.35 (unch)

Bio-Rad Launches Vitamin D Kit for Its BioPlex 2200 System
Marketwire - Mon Jun 23, 3:15PM CDT
Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO. , today announced the launch of the BioPlex(R) 2200 25-OH Vitamin D kit for use outside the U.S. on the company's BioPlex(R) 2200 system. The assay offers a fully-automated method for the quantitative measurement of total 25-hydroxyvitamin D in human serum.
BIO: 118.36 (+0.79), BIO.B: 117.35 (unch)

Bio-Rad unveils fifth generation fully-automated HIV screening test
M2 - Wed Jun 18, 6:06AM CDT
Life science company Bio-Rad Laboratories (NYSE:BIO) (NYSE:BIO. revealed on Tuesday the availability of its fifth generation HIV test, the BioPlex 2200 HIV Ag-Ab kit.
BIO: 118.36 (+0.79), BIO.B: 117.35 (unch)

Bio-Rad Launches the First Fully-Automated 5th Generation HIV Test
Marketwire - Wed Jun 18, 1:34AM CDT
Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO. , a global manufacturer and distributor of life science research and clinical diagnostic products, today announced the launch of its BioPlex(R) 2200 HIV Ag-Ab kit, the company's 5th generation HIV test for markets outside the U.S.
BIO: 118.36 (+0.79), BIO.B: 117.35 (unch)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JiMMYBAR! Unveils World's First Creatine Trail Mix

The New Face of Snacking: Creatine Trail Mix I'll tell you right off the bat, JiMMYBAR! seems to be cornering the snack world with an odd—but interesting—twist. They've just launched the world's first Creatine + Protein Trail Mix, blending muscle-building nutrients with the classic crunch of trail mix. Sounds quirky, and it’s exclusive to their site, JiMMYBARs.com....

Jaguar Promise Tackles College Cost for Texas Students

Transforming Aspirations into Achievements In the heart of San Antonio, something’s cooking at A&M University-San Antonio, and it's not just the classic breakfast tacos. They've hit a record-breaking enrollment of 7,697 students this Fall, with 1,322 being fresh-faced first-timers. And while that might grab your attention, the real headliner is their Jaguar Promise...

xFusion Tackles Cooling and Power at OCP 2026

Bracing for an AI Revolution Ah, the world of AI — it's like the wild west out there, with data centers struggling to keep up as workloads skyrocket. Enter xFusion, a veteran in the computing infrastructure game, rolling out some seriously impressive tech at the 2026 Open Compute Project (OCP) Global Summit. The company's latest offering showcases how they're tackling...

Puori Protein Transparency Pays Off Amid Lead Scare

Puori's Moment of Reckoning The world of nutritional supplements is no stranger to controversy, but when Puori found itself caught in the storm of the Consumer Reports investigation last year, it chose a road less traveled: transparency and accountability. Faced with alarming news that over two-thirds of tested protein powders exceeded California's Proposition 65 lead...

New Data on SKYRIZI Offers Hope for Crohn's Patients

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Honeywell Aerospace Faces Legal Turbulence in Fraud Case

If you've got your chips on Honeywell Aerospace, Inc. (HONA), buckle up because things are getting choppy. Investors who took a bath on their shares now have the chance to put on their legal gloves and join a securities fraud class action lawsuit against the company. Legal Storm Over Misleading Statements Here's the rub: Between June 29 and September 1, 2026, the folks at...

AI-Powered Travel Transformation in Norway Revealed

AI-Driven Travel Meets Norway's Authentic Charm Well, folks, once again we're staring down the barrel of technology going full throttle in the travel game. Mindtrip, the savvy AI-powered travel platform, just inked a deal with the Norwegian Travel Cluster. It's their first tango in Europe, and they're not dipping their toes—they're diving headfirst into the icy fjords....

Tessa AI: Revolutionizing Biomedical Research with AI

Shaking Up Research Evaluation When Siensmetrica decided it was high time for a name change, morphing into Tessa AI wasn't just a cosmetic shift. It was a nod to what stakeholders were already calling it and laid the ground for a broader mission statement. They're not sitting on their hands; they're crafting tools that tackle the scientific life cycle from start to...

Laars Welcomes Women in Manufacturing to Facility Tour

Opening Doors and Minds in Manufacturing On October 15, Laars Heating Systems throws wide open its Rochester, N.H., facility to a group that's rewriting the rulebook: women in manufacturing. It's not just another day in the life of assembly lines and engineering desks, folks. This is about giving a platform to those often sidelined in the field of boilers and water...

WIN Expands Leadership Amidst Rapid Growth Surge

Why WIN's Leadership Shake-Up Matters Change is afoot at the fertility and family support powerhouse WIN, and there's no mistaking the bold handwriting on the wall. As they swell towards supporting one million families, WIN's revamping their leadership table with three key players aimed at pushing the envelope further than before. They've got Claudio Stefan, Stacey...